Walgreens Boots Alliance, Inc. presents a complex yet intriguing dividend profile. Despite a history of consistent dividend payments over the past 40 years, recent challenges paint a cautious outlook for investors. With an exceptionally high dividend yield of 11.55% and a recent cut in 2024, stakeholders must consider the sustainability of these returns. The company's payout ratios indicate potential financial strain, raising questions about future dividend continuity.
Walgreens Boots Alliance operates in the Health Services sector. The current dividend yield is a striking 11.55%, resulting from a notable dividend per share standing at $1.46. Over its 40-year continuous payment history, Walgreens has demonstrated a reliable dividend record up until the recent cut in 2024.
Metric | Details |
---|---|
Sector | Health Services |
Dividend yield | 11.55 % |
Current dividend per share | 1.46 USD |
Dividend history | 40 years |
Last cut or suspension | 2024 |
Walgreens' dividend history highlights resiliency, contributing to investor confidence. The recent cut in 2024 introduces uncertainty, warranting a closer examination of its implications.
Year | Dividend Per Share (USD) |
---|---|
2024 | 1.00 |
2023 | 1.92 |
2022 | 1.915 |
2021 | 1.890 |
2020 | 1.850 |
The growth rate has been diminishing, with a 3-year growth of -0.19% and a 5-year rate of -0.11%, reflecting pressures on profitability and future dividend expansions.
Time | Growth |
---|---|
3 years | -0.19 % |
5 years | -0.11 % |
The average dividend growth is -0.11% over 5 years. This shows moderate but steady dividend growth.
Payout analysis unveils a concerning picture; an EPS-based payout ratio of -21.83% and a free cash flow-based ratio of 221.08% suggest challenges in sustaining dividends. These metrics need addressing to reassure potential investors.
Key figure | Ratio |
---|---|
EPS-based | -21.83 % |
Free cash flow-based | 221.08 % |
These figures indicate an unsustainable payout considering the current earnings deficit and high cash utilization.
Robust cashflow is essential for dividend health. Walgreens' free cash flow yield stands at 6.12%, yet significant portions are tied up, limiting CAPEX and increasing operational risks.
Year | 2022 | 2023 | 2024 |
---|---|---|---|
Free Cash Flow Yield | 7.14% | 0.65% | -4.55% |
Earnings Yield | 14.31% | -14.10% | -108.17% |
CAPEX to Operating Cash Flow | 44.47% | 93.76% | 135.66% |
Stock-based Compensation to Revenue | 0.29% | 0.28% | 0.12% |
Free Cash Flow / Operating Cash Flow Ratio | 55.53% | 6.24% | -35.66% |
Cashflow metrics call for caution with high CAPEX impacting further dividend payouts and overall capital retention.
Debt levels pose potential risks to dividend policy, illustrated by a high debt-to-equity ratio and leverage indicators.
Year | 2022 | 2023 | 2024 |
---|---|---|---|
Debt-to-Equity | 1.21 | 1.67 | 3.15 |
Debt-to-Assets | 39.36% | 34.70% | 40.54% |
Debt-to-Capital | 54.71% | 62.62% | 75.88% |
Net Debt to EBITDA | 6.89 | 9.43 | -9.76 |
Current Ratio | 0.75 | 0.63 | 0.61 |
Quick Ratio | 0.38 | 0.30 | 0.37 |
Financial Leverage | 3.07 | 4.83 | 7.76 |
Leverage metrics suggest heightened financial risk, necessitating vigilant management to ensure long-term solvency.
The fundamentals reveal alarming dips in profitability, affecting overall capital dynamics and putting dividend safety at risk.
Year | 2022 | 2023 | 2024 |
---|---|---|---|
Return on Equity | 14.77% | -15.38% | -82.68% |
Return on Assets | 4.81% | -3.19% | -10.66% |
Margins: Net | 3.27% | -2.21% | -5.85% |
Margins: EBIT | 2.47% | -3.48% | -9.30% |
Margins: EBITDA | 3.73% | 2.50% | -7.64% |
Margins: Gross | 21.30% | 19.47% | 17.96% |
Research & Development to Revenue | 0% | 0% | 0% |
The deteriorating margins and returns highlight pressure on operational effectiveness, critical for future dividend stability.
Category | Score (1-5) | Score Bar |
---|---|---|
Dividend yield | 5 | |
Dividend Stability | 2 | |
Dividend growth | 1 | |
Payout ratio | 1 | |
Financial stability | 1 | |
Dividend continuity | 2 | |
Cashflow Coverage | 1 | |
Balance Sheet Quality | 1 |
Walgreens Boots Alliance's dividend profile presents significant challenges. Investors should exercise caution given the financial headwinds impacting dividend visibility and sustainability. A prudent approach is advised until recovery signs become evident.